193 related articles for article (PubMed ID: 18005095)
1. Vascular adhesion protein-1 in human ischaemic stroke.
Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
[TBL] [Abstract][Full Text] [Related]
2. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J
Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
4. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
5. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular adhesion protein-1 in atopic eczema.
Madej A; Reich A; Orda A; Szepietowski JC
Int Arch Allergy Immunol; 2006; 139(2):114-21. PubMed ID: 16361866
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
[TBL] [Abstract][Full Text] [Related]
8. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.
Salmi M; Stolen C; Jousilahti P; Yegutkin GG; Tapanainen P; Janatuinen T; Knip M; Jalkanen S; Salomaa V
Am J Pathol; 2002 Dec; 161(6):2255-62. PubMed ID: 12466139
[TBL] [Abstract][Full Text] [Related]
9. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
10. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
[TBL] [Abstract][Full Text] [Related]
11. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
12. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
13. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy.
Murata M; Noda K; Fukuhara J; Kanda A; Kase S; Saito W; Ozawa Y; Mochizuki S; Kimura S; Mashima Y; Okada Y; Ishida S
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4055-62. PubMed ID: 22618595
[TBL] [Abstract][Full Text] [Related]
14. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
15. Elevated soluble intercellular adhesion molecule-1 levels are associated with poor short-term prognosis in middle-aged patients with acute ischaemic stroke.
Rallidis LS; Zolindaki MG; Vikelis M; Kaliva K; Papadopoulos C; Kremastinos DT
Int J Cardiol; 2009 Feb; 132(2):216-20. PubMed ID: 18191248
[TBL] [Abstract][Full Text] [Related]
16. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
[TBL] [Abstract][Full Text] [Related]
17. SSAO/VAP-1 protein expression during mouse embryonic development.
Valente T; Solé M; Unzeta M
Dev Dyn; 2008 Sep; 237(9):2585-93. PubMed ID: 18729210
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
19. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
20. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
